In Reply: The benefits and harms of breast cancer screening

The Lancet

Volumn 381, Issue 9869, 2013, Pages 800-801

  Paci, Eugenio ^a   Broeders, Mireille ^b   Hofvind, Solveig ^c,d   Duffy, Stephen W ^e  

^a CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c CANCER REGISTRY OF NORWAY   (Norway)

^d OSLO METROPOLITAN UNIVERSITY   (Norway)

^e QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; BREAST CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; CASE CONTROL STUDY; DIAGNOSTIC ERROR; HUMAN; LETTER; OBSERVATIONAL STUDY; PREVALENCE; PRIORITY JOURNAL; PUBLICATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); UNITED KINGDOM; BREAST TUMOR; EARLY DIAGNOSIS; FEMALE; MASS SCREENING; METHODOLOGY; NOTE;

BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MASS SCREENING;

EID: 84874701486     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(13)60622-4     Document Type: Letter

References (5)

1. Independent UK Panel on Breast Cancer Screening. The benefits and harms of breast cancer screening: an independent review. Lancet 2012; 380: 1778-86.
2. Broeders M, Moss S, Nyström L, et al. The impact of mammographic screening on breast cancer mortality in Europe: a review of observational studies. J Med Screen 2012; 19 (suppl 1): 14-25.
3. Puliti D, Duffy S, Miccinesi G, et al. Overdiagnosis in mammographic screening for breast cancer in Europe: a literature review. J Med Screen 2012; 19 (suppl 1): 42-56.
4. Yen AM, Duffy SW, Chen TH, et al. Long-term incidence of breast cancer by trial arm in one county of the Swedish Two-County Trial of mammographic screening. Cancer 2012; 118: 5728-32.
5. Giordano L, Cogo C, Patnick J, Paci E, Euroscreen working group. Communicating the balance sheet in breast cancer screening. J Med Screen 2012; 19 (suppl 1): 67-71.